Join the 200th Anniversary Celebration

Original Article

Surgical versus Nonsurgical Therapy for Lumbar Spinal Stenosis

James N. Weinstein, D.O., M.S., Tor D. Tosteson, Sc.D., Jon D. Lurie, M.D., M.S., Anna N.A. Tosteson, Sc.D., Emily Blood, M.S., Brett Hanscom, M.S., Harry Herkowitz, M.D., Frank Cammisa, M.D., Todd Albert, M.D., Scott D. Boden, M.D., Alan Hilibrand, M.D., Harley Goldberg, D.O., Sigurd Berven, M.D., and Howard An, M.D. for the SPORT Investigators

N Engl J Med 2008; 358:794-810February 21, 2008

Abstract

Background

Surgery for spinal stenosis is widely performed, but its effectiveness as compared with nonsurgical treatment has not been shown in controlled trials.

Methods

Surgical candidates with a history of at least 12 weeks of symptoms and spinal stenosis without spondylolisthesis (as confirmed on imaging) were enrolled in either a randomized cohort or an observational cohort at 13 U.S. spine clinics. Treatment was decompressive surgery or usual nonsurgical care. The primary outcomes were measures of bodily pain and physical function on the Medical Outcomes Study 36-item Short-Form General Health Survey (SF-36) and the modified Oswestry Disability Index at 6 weeks, 3 months, 6 months, and 1 and 2 years.

Results

A total of 289 patients were enrolled in the randomized cohort, and 365 patients were enrolled in the observational cohort. At 2 years, 67% of patients who were randomly assigned to surgery had undergone surgery, whereas 43% of those who were randomly assigned to receive nonsurgical care had also undergone surgery. Despite the high level of nonadherence, the intention-to-treat analysis of the randomized cohort showed a significant treatment effect favoring surgery on the SF-36 scale for bodily pain, with a mean difference in change from baseline of 7.8 (95% confidence interval, 1.5 to 14.1); however, there was no significant difference in scores on physical function or on the Oswestry Disability Index. The as-treated analysis, which combined both cohorts and was adjusted for potential confounders, showed a significant advantage for surgery by 3 months for all primary outcomes; these changes remained significant at 2 years.

Conclusions

In the combined as-treated analysis, patients who underwent surgery showed significantly more improvement in all primary outcomes than did patients who were treated nonsurgically. (ClinicalTrials.gov number, NCT00000411.)

Media in This Article

Figure 1Enrollment, Randomization, and Follow-up.
Figure 2Primary Outcomes in the Randomized and Observational Cohorts during 2 Years of Follow-up.
Article

Spinal stenosis is a narrowing of the spinal canal with encroachment on the neural structures by surrounding bone and soft tissue. Patients typically present with radicular leg pain or with neurogenic claudication (pain in the buttocks or legs on walking or standing that resolves with sitting down or lumbar flexion). Spinal stenosis is the most common reason for lumbar spine surgery in adults over the age of 65 years.1,2 Indications for surgery appear to vary widely, and rates of procedures vary by at least a factor of 5 across geographic areas.3,4 Radiographic evidence of stenosis is frequently asymptomatic; thus, careful clinical correlation between symptoms and imaging is critical.5,6

A 2005 Cochrane review found that the paucity and heterogeneity of evidence limited conclusions regarding surgical efficacy for spinal stenosis. The trials comparing surgical with nonsurgical treatment were generally small and involved patients both with and without degenerative spondylolisthesis.7-12 We know of no randomized trials of isolated spinal stenosis without degenerative spondylolisthesis.

In the Spine Patient Outcomes Research Trial (SPORT), we report on the 2-year outcomes of patients with spinal stenosis without degenerative spondylolisthesis to analyze the relative efficacy of surgical versus nonsurgical treatment.

Methods

Study Design

SPORT was an investigator-initiated study conducted in 11 states at 13 U.S. medical centers with multidisciplinary spine practices. The study included both a randomized cohort and a concurrent observational cohort of patients who declined to undergo randomization.13-16 This design allowed for improved generalizability of the findings.17 The ethics committee at each participating institution approved a standardized protocol. An independent data and safety monitoring board evaluated interim safety and efficacy outcomes at 6-month intervals.13-16,18 Stopping rules were provided on the basis of the alpha spending function of DeMets and Lan.19

Patient Population

All patients had a history of neurogenic claudication or radicular leg symptoms for at least 12 weeks and confirmatory cross-sectional imaging showing lumbar spinal stenosis at one or more levels; all patients were judged to be surgical candidates. Patients with degenerative spondylolisthesis were studied separately.16 Patients with lumbar instability (which was defined as translation of more than 4 mm or 10 degrees of angular motion between flexion and extension on upright lateral radiographs) were excluded. The type of nonsurgical care before enrollment was not prespecified but included physical therapy (68% of patients), epidural injections (56%), chiropractic (28%), the use of antiinflammatory drugs (55%), and the use of opioid analgesics (27%).

Research nurses at each site verified eligibility. Patients were offered enrollment in either cohort. To aid in obtaining written informed consent, patients viewed evidence-based videotapes with standardized information regarding alternative treatments.20,21 Patients in the randomized cohort received treatment assignments with the use of randomly permuted blocks with variable block sizes stratified according to center. Patients in the observational cohort chose their treatment at enrollment with their physician. Enrollment began in March 2000 and ended in March 2005.

Study Interventions

The protocol surgery was standard posterior decompressive laminectomy.13 The nonsurgical protocol was “usual care,” which was recommended to include at least active physical therapy, education or counseling with home exercise instruction, and the administration of nonsteroidal antiinflammatory drugs, if tolerated.13,18

Study Measures

Primary outcomes were measures of bodily pain and physical function on the Medical Outcomes Study 36-item Short-Form General Health Survey (SF-36)22-25 and on the modified Oswestry Disability Index (American Academy of Orthopaedic Surgeons–MODEMS [Musculoskeletal Outcomes Data Evaluation and Management Systems] version),26 measured at 6 weeks, 3 months, 6 months, and 1 and 2 years. (SF-36 scores range from 0 to 100, with higher scores indicating less severe symptoms. The Oswestry Disability Index ranges from 0 to 100, with lower scores indicating less severe symptoms.)

If surgery was delayed beyond 6 weeks, additional follow-up data were obtained at 6 weeks and at 3 months after surgery. Secondary outcomes included patient-reported improvement, satisfaction with current symptoms and care,27 and the bothersomeness of both stenosis7,28 and low back pain.7 The effect of treatment was defined as the difference in the mean change from baseline between the surgical group and the nonsurgical group.

Statistical Analysis

For the randomized cohort, we determined that a sample size of 185 per group was needed to detect a 10-point difference in bodily pain and physical function on the SF-36 or a similar effect on the Oswestry Disability Index13 on the basis of a t-test, with a two-sided significance level of 0.05 and a power of 85%. Standard deviations for changes from baseline were derived from pilot data on repeated visits. The sample-size calculation allowed for 20% missing data but did not account for any specific levels of nonadherence.

Initial analyses compared the baseline characteristics of patients in the randomized cohort with those in the observational cohort and between study groups in the combined cohorts. The extent of missing data and the percentage of patients undergoing surgery were calculated according to study group for each scheduled follow-up. Baseline predictors of the time until surgical treatment (including treatment crossovers) in both cohorts were determined through a stepwise proportional-hazards regression model with an inclusion criterion of P<0.1 to enter and P>0.05 to exit. Predictors of missing follow-up visits at 1 year were determined through stepwise logistic regression.

Primary analyses compared surgical and nonsurgical treatments with the use of changes from baseline at each follow-up visit, with a mixed-effects model of longitudinal regression that included a random individual effect to account for correlation between repeated measurements. The randomized cohort was initially analyzed on an intention-to-treat basis. Because of crossover, subsequent analyses were based on treatments actually received. In the as-treated analyses, the treatment indicator was a time-varying covariate, allowing for variable times of surgery. For the intention-to-treat analyses, all times are from enrollment. For the as-treated analysis, the times are from the beginning of treatment (i.e., the time of surgery for the surgical group and the time of enrollment for the nonsurgical group). Therefore, all changes from baseline before surgery were included in the estimates of the nonsurgical treatment effect. After surgery, changes were assigned to the surgical group, with follow-up measured from the date of surgery. Repeated measures of outcomes were used as the dependent variables, and treatment received was included as a time-varying covariate. Adjustments were made for the time of surgery with respect to the original enrollment date so as to approximate the designated follow-up times.

The randomized and observational cohorts were each analyzed to produce separate as-treated estimates of treatment effect. These results were compared with the use of a Wald test to simultaneously test all follow-up visit times for differences in estimated treatment effects between the two cohorts.29 Subsequent analyses combined the two cohorts.

To adjust for potential confounding, baseline variables that were associated with missing data or treatment received were included as adjusting covariates in longitudinal regression models.29 Computations were performed with the use of the PROC MIXED procedure for continuous data and the PROC GENMOD procedure for binary and non-normal secondary outcomes in SAS software, version 9.1 (SAS Institute). Statistical significance was defined as P<0.05 on the basis of a two-sided hypothesis test with no adjustments made for multiple comparisons. Data for these analyses were collected through March 2, 2007.

Results

Patients

A total of 654 patients were enrolled out of 1091 who were eligible for enrollment: 289 in the randomized cohort and 365 in the observational cohort (Figure 1Figure 1Enrollment, Randomization, and Follow-up.). In the randomized cohort, 138 patients were assigned to the surgical group, and 151 were assigned to the nonsurgical group. In the surgery group, 63% had undergone surgery at 1 year and 67% at 2 years. In the nonsurgical group, 42% had undergone surgery at 1 year and 43% at 2 years. In the observational cohort, 219 patients initially chose surgery and 146 patients initially chose nonsurgical care. Of those who initially chose surgery, 95% had undergone surgery at 1 year and 96% at 2 years. Of those who initially chose nonsurgical treatment, 17% had undergone surgery at 1 year and 22% at 2 years. In the two cohorts combined, 400 patients received surgery at some point during the first 2 years, and 254 received nonsurgical treatment.

The proportion of enrollees who supplied data at each follow-up interval ranged from 83 to 89%, with losses due to dropouts, missed visits, or deaths. A total of 634 patients, each with at least one follow-up through 2 years, were included in the analysis, including 278 patients (96%) in the randomized cohort and 356 patients (98%) in the observational cohort.

Characteristics of the Patients

Characteristics of the patients at baseline in the two cohorts are compared in Table 1Table 1Demographic Characteristics, Coexisting Illnesses, and Measures of Health Status of the Patients.. Overall, the cohorts were similar. However, patients in the observational cohort had more signs of nerve-root tension and less lateral recess stenosis and expressed stronger treatment preferences than did patients in the randomized cohort.

Summary statistics for the combined cohorts are also shown in Table 1, according to treatment received. The study population had a mean age of 65 years; a majority were white men who had attended college. Of these patients, 80% had classic neurogenic claudication, and 79% had associated dermatomal pain radiation; 91% had stenosis at L4 or L5, and 61% had more than one level of stenosis. For most patients, the overall stenosis was graded as severe.

At baseline, the group undergoing surgery was younger and more likely to be working than was the group that did not undergo surgery. Patients in the surgical group had more pain, a lower level of function, more psychological distress, and more self-reported disability than did patients in the nonsurgical group. In addition, patients in the surgical group had symptoms that were more bothersome and radiographic evidence of more severe stenosis. The surgical group was more often dissatisfied with their symptoms and more often rated the symptoms as worsening than did patients in the nonsurgical group.

The final models, combining both cohorts, were adjusted for age, sex, coexisting disorders of the stomach or joints, the presence or absence of pain on straight-leg raising or femoral-nerve tension signs, smoking status, patient-assessed health trend, income, other compensation, body-mass index, baseline score for the outcome variable, and center.

Nonsurgical Treatments

At 2 years, nonsurgical treatments were similar in the two cohorts. However, more patients in the randomized group than in the observational group reported visits to a surgeon (45% vs. 32%, P=0.02) and receiving injections (52% vs. 39%, P=0.02), whereas more patients in the observational group reported the use of “other” medications, such as gabapentin (60% vs. 73%, P=0.01).

Surgical Treatments and Complications

Overall, surgical treatments and complications were similar in the two cohorts (Table 2Table 2Surgical Treatments, Complications, and Events.). Among patients in the surgical group, 89% underwent decompression only. Instrumented fusion was performed in only 6% of patients. The median surgical time was 120 minutes, with a mean blood loss of 314 ml; 10% of patients required transfusions intraoperatively and 5% postoperatively. The most common surgical complication was dural tear, in 9% of patients. At 2 years, reoperation had occurred in 8% of patients; fewer than half of these operations were for recurrent stenosis.

At 2 years, there were seven deaths in the nonsurgical group and six in the surgical group, one of which occurred within 3 months after surgery. The deaths were reviewed and 12 were judged not to be treatment-related. The one death of unknown cause occurred 501 days after surgery.

Crossover

Nonadherence to treatment assignment affected both study cohorts: some patients in the surgical group chose to delay or decline surgery, and some in the nonsurgical group crossed over to undergo surgery (Figure 1). The characteristics of crossover patients that differed significantly from patients who did not cross over are shown in Table 3Table 3Significant Predictors of Treatment Received within 2 Years among Patients in the Randomized Cohort.. Patients in the nonsurgical group who crossed over to undergo surgery had more self-rated disability, more psychological distress, worse symptoms, and a stronger treatment preference for surgery at baseline than did patients who did not opt for surgery. Patients in the surgical group who crossed over to receive nonsurgical care were more often not white, had less bothersome symptoms, less often rated their symptoms as worsening at enrollment, and had a stronger treatment preference for nonsurgical care at baseline.

Main Treatment Effects

In the intention-to-treat analysis, a significant treatment effect favoring surgery was seen at 2 years, with a mean difference in change from baseline of 7.8 (95% confidence interval [CI], 1.5 to 14.1) on the SF-36 scale for bodily pain; at earlier times, there was a smaller nonsignificant effect in favor of surgery. However, at 2 years, there were no significant differences between the surgical group and the nonsurgical group on the SF-36 scale for physical function (0.1; 95% CI, −6.4 to 6.5) or on the Oswestry Disability Index (−3.5; 95% CI, −8.7 to 1.7) (Table 4Table 4Intention-to-Treat Analysis for the Randomized Cohort and Adjusted Analyses, According to Treatment Received, for the Randomized and Observational Cohorts Combined.).

In the as-treated analysis, the mean differences in change from baseline in the randomized and observational cohorts were similar at 2 years: bodily pain, 11.7 (95% CI, 6.2 to 17.2) in the randomized group versus 15.3 (95% CI, 10.4 to 20.2) in the observational group; physical function, 8.1 (95% CI, 2.8 to 13.5) in the randomized group versus 13.6 (95% CI, 8.7 to 18.4) in the observational group; and Oswestry Disability Index, −8.7 (95% CI, −13.3 to −4.0) in the randomized group versus −13.1 (95% CI, −16.9 to −9.2) in the observational group (Figure 2Figure 2Primary Outcomes in the Randomized and Observational Cohorts during 2 Years of Follow-up.).

The global hypothesis test comparing the as-treated effects in the randomized group and the observational group over all time periods showed no difference between the two cohorts (P=0.93 for bodily pain, P=0.67 for physical function, and P=0.60 for the Oswestry Disability Index).

Results from the intention-to-treat analysis and the as-treated analysis of the two cohorts are compared in Figure 2. The effects shown in the as-treated analysis significantly favored surgery in both cohorts. In the combined analysis, treatment effects were significant in favor of surgery for all primary and secondary outcome measures at each time point during the 2 years (Table 4).

Discussion

In patients with imaging-confirmed spinal stenosis without spondylolisthesis and leg symptoms persisting for at least 12 weeks, surgery was superior to nonsurgical treatment in relieving symptoms and improving function. In the as-treated analysis, the treatment effect for surgery was seen as early as 6 weeks, appeared to reach a maximum at 6 months, and persisted for 2 years; it is notable that the condition of patients in the nonsurgical group improved only moderately during the 2-year period. The intention-to-treat results must be viewed in the context of the substantial rates of nonadherence to assigned treatment. The pattern of nonadherence was striking because both the surgical and the nonsurgical groups were affected, unlike the results of many studies involving surgical procedures.30 The mixing of treatments owing to crossover can be expected to create a bias toward the null.31 The large effects seen in the as-treated analysis and the characteristics of the crossover patients suggest that the intention-to-treat analysis underestimated the true effect of surgery.

This study provides an opportunity to compare results involving patients who were willing to participate in a randomized study (randomized cohort) and those who were unwilling to participate in such a study (observational cohort).13-16 These two cohorts were remarkably similar at baseline. Other than treatment preference, the only significant differences were small ones in signs of nerve-root tension and the location of stenosis. The two cohorts also had similar outcomes, without significant differences in the as-treated analyses. Given these similarities, the combined analyses are well justified. Although these analyses are not based on randomized treatment assignments, the results are strengthened by the use of specific inclusion and exclusion criteria, the sample size, and adjustment for potentially confounding baseline differences.32

The characteristics of the patients were similar to those in previous studies, even though the latter involved mixed-cohort patients (i.e., those with or without spondylolisthesis). In our study, the functional status of the patients at baseline was similar to that of patients in the Maine Lumbar Spine Study7,8 (SF-36 score, 34.8 and 35.0, respectively) but worse than that in the study by Malmivaara et al.10,11 (Oswestry Disability Index, 42.4 and 35.0, respectively).

In the as-treated analysis, the functional improvement in the surgical group at 1 year was very similar to that in the Maine Lumbar Spine Study (26.5 and 27.0, respectively) but greater than in the study by Malmivaara et al. (Oswestry Disability Index, −21.4 and −11.3, respectively). Functional improvement in the nonsurgical group was greater in our study than in the previous studies, with a change of 10.5 in the SF-36 physical function score at 1 year, as compared with 1.0 in the Maine Lumbar Spine Study, and a change of 9.3 in the Oswestry Disability Index at 2 years, as compared with 4.5 in the study by Malmivaara et al. The greater improvements in our study, compared with those in the study by Malmivaara et al., may be related to differences in the selection of patients. In the study by Malmivaara et al., patients with moderate spinal stenosis were specifically selected, whereas in our study, we attempted to enroll patients with spinal stenosis who were surgical candidates.

In the as-treated analysis, we can directly compare the estimates of treatment effect with those of the previous studies. The estimated 1-year treatment effects for surgery were smaller in our study than in the Maine Lumbar Spine Study (changes in bodily pain of 14.6 and 30.4, respectively, and in physical function of 15.9 and 25.5, respectively). However, in the Maine Lumbar Spine Study, treatment effects for baseline differences between the study groups were not adjusted, which probably explains these discrepancies. At 1 year, the estimated treatment effects were similar in our study and the study by Malmivaara et al.: Oswestry Disability Index, −12.5 and −11.3, respectively; leg pain, 17% (on a 7-point scale) and 15% (on an 11-point scale); and back pain, 14% (on a 7-point scale) and 21% (on an 11-point scale).

It is interesting that among patients who underwent surgery, the magnitude of the mean changes in patients with spinal stenosis was nearly identical to that in the patients with degenerative spondylolisthesis at 2 years: bodily pain, 26.9 and 29.9, respectively; physical function, 23.0 and 26.6; Oswestry Disability Index, −20.5 and −24.2; and bothersomeness of symptoms, −7.8 and −8.9.16 The treatment effects in these studies of spinal stenosis were larger than those in the observational study of patients with intervertebral disk herniation because of strong improvements in the nonsurgical group of patients with intervertebral disk herniation that were not seen in either stenosis group.14-16

There was little evidence of harm from either treatment. Often patients fear they will get worse without surgery, but this was not the case for the majority of patients in the nonsurgical group, who, on average, showed small improvements in all outcomes. The 1-year rate of reoperation for recurrent stenosis was 1.3%, a rate similar to those reported by Malmivaara et al. (2%) and by the Maine Lumbar Spine Study (1.2%). At 2 years, mortality was nearly the same in the two study groups and was lower than actuarial projections. The postoperative death rate of 0.3% and the overall postoperative complication rate of 12% were slightly better than the reported Medicare rates in patients with spinal stenosis who did not undergo spinal fusion (death rate, 0.8%; rate of complications, 14%).1 However, higher rates of complications have been reported with increasing age and coexisting medical conditions.33

The primary limitation of our study was the marked degree of nonadherence to randomized treatment. This factor reduced the power of the intention-to-treat analysis to show treatment effects, though there was still a significant treatment effect for the measure of bodily pain at 2 years. The as-treated analyses do not share the strong protection from confounding that exists for the intention-to-treat analyses. However, these analyses were carefully adjusted for important baseline covariates and yielded results similar to those of previous studies. The characteristics of the crossover patients were as one might expect: those with severe symptoms and a preference for surgery crossed over into the surgical group, and vice versa.

Another limitation was the heterogeneity of the nonsurgical treatments. Given the limited evidence regarding efficacy of most nonsurgical treatments for spinal stenosis and individual variability in response, the creation of a limited, fixed protocol for nonsurgical treatment was neither clinically feasible nor generalizable. The flexible treatment protocols allowed for individualization of nonsurgical treatment plans, reflect current practice among multidisciplinary spine practices, and were consistent with published guidelines.34,35 However, we did not assess the effect of surgery versus any specific nonsurgical treatment.

In conclusion, in the as-treated analysis, if we combine the randomized and observational cohorts, carefully adjusting for potentially confounding baseline factors, patients with spinal stenosis without degenerative spondylolisthesis who underwent surgery showed significantly greater improvement in pain, function, satisfaction, and self-rated progress than did patients who were treated nonsurgically.

Supported by a grant (U01-AR45444-01A1) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institutes of Health Office of Research on Women's Health, the National Institute of Occupational Safety and Health of the Centers for Disease Control and Prevention, a grant (P60-AR048094-01A1) to the Multidisciplinary Clinical Research Center in Musculoskeletal Diseases from NIAMS, and a Research Career Award (1-K23-AR-048138-01, to Dr. Lurie) from NIAMS.

Dr. Lurie reports receiving grant support from St. Francis Medical Technologies and the American Board of Orthopaedic Surgery and consulting fees from Merck, Ortho-McNeil, Pfizer, Centocor, Myexpertdoctor.com, Pacific Business Group on Health, and the Foundation for Informed Medical Decision Making; Dr. A.N.A. Tosteson, receiving grant support from St. Francis Medical Technologies and Zimmer; Dr. Cammisa, having an equity interest in K2M, Spinal Kinetics, and HealthPoint Capital Partners; Dr. Albert, receiving consulting fees and royalties from DePuy Spine and having an equity interest in K2M; Dr. Boden, receiving consulting fees from Medtronic and lecture fees from Osteotech; and Dr. Berven, receiving grant support from Medtronic. No other potential conflict of interest relevant to this article was reported.

We thank Tamara S. Morgan, Department of Orthopaedic Surgery, Dartmouth Medical School, for graphic design and assistance with the manuscript and the following members of the data and safety monitoring board: Ron Thisted, Ph.D. (chair), University of Chicago, Chicago; Tim Carey, M.D., M.P.H., University of North Carolina at Chapel Hill, Chapel Hill; Peter C. Gerszten, M.D., Presbyterian University Hospital, Pittsburgh; Ed Hanley, M.D., Carolina Health Care, Charlotte, NC; and Bjorn Ryedvik, M.D., Ph.D., Sahlgrenska University Hospital, Gothenburg, Sweden. This study is dedicated to the memory of Brieanna Weinstein.

Source Information

From the Departments of Orthopedics (J.N.W., E.B., B.H.), Community and Family Medicine (T.D.T., J.D.L., A.N.A.T.), and Medicine (J.D.L., A.N.A.T.), Dartmouth Medical School, Hanover, NH, and Dartmouth–Hitchcock Medical Center, Lebanon, NH; William H. Beaumont Hospital, Royal Oak, MI (H.H.); Hospital for Special Surgery, New York (F.C.); Rothman Institute at Thomas Jefferson University, Philadelphia (T.A., A.H.); Emory Spine Center, Emory University, Atlanta (S.D.B.); Kaiser Permanente, San Francisco (H.G.); University of California at San Francisco, San Francisco (S.B.); and Rush–Presbyterian–St. Luke's Medical Center, Chicago (H.A.).

Address reprint requests to Dr. Weinstein at the Dartmouth Institute for Health Policy and Clinical Practice, Department of Orthopedics, Dartmouth Medical School, 1 Medical Center Dr., Lebanon, NH 03756, or at .

Investigators in the Spine Patient Outcomes Research Trial (SPORT) are listed in the Appendix.

Appendix

In addition to the authors, the following investigators participated in the study, with institutions listed in order from highest to lowest enrollment of patients: William Beaumont Hospital, Royal Oak, MI: G. Bradley, M. Lurie, J. Fischgrund, D. Montgomery, L. Kurz, E. Truumees; Washington University, St. Louis: L. Lenke, G. Stobbs, A. Margherita, H. Prather, K. Bridwell, K.S. Riew, C. Lauryssen, B. Taylor, J. Metzler; Dartmouth Medical School, Lebanon, NH: J. Forman, W. Abdu, B. Butler-Schmidt, J.J. Hebb, P. Ball, P. Bernini, H. Magnadottir, R. Rose, R. Roberts, R. Diegel, S. Banerjee, R. Beasely; Emory University, Atlanta: S. Lashley, J. Heller, H. Levy, S.T. Yoon, M. Schaufele, W. Horton; Rothman Institute at Thomas Jefferson Hospital, Philadelphia: C. Simon, M. Freedman, O'Brien, S. Dante, T. Conliffe; University Hospitals of Cleveland and Case Western Reserve University, Cleveland: S. Emery, C. Furey, K. Higgins, J.X. Yoo, H. Bohlman, E.B. Marsolais, R.S. Krupkin; Hospital for Special Surgery, New York: B. Green, O. Boachie-Edjei, J. Farmer; Nebraska Foundation for Spinal Research, Omaha: M. Longley, N. Fullmer, A.M. Fredericks, J. Fuller, R. Woodward, J. McClellan, E. Phillips, T. Burd, P. Bowman; University of California at San Francisco, San Francisco: P. Malone, D. Bradford, S. Deviren, P. Weinstein, T. Smith; Hospital for Joint Diseases, New York: T. Errico, A. Lee, J. Goldstein, J. Spivak, R. Perry, J. Bendo, R. Moskovich; Rush–Presbyterian–St. Luke's Medical Center, Chicago: G. Andersson, M. Hickey, E. Goldberg, F. Phillips, R. Massimino, S. Petty; Kaiser Permanente, Oakland, CA: H. Goldberg; Maine Spine and Rehabilitation, Scarborough: R. Keller.

References

References

  1. 1

    Deyo RA, Ciol MA, Cherkin DC, Loeser JD, Bigos SJ. Lumbar spinal fusion: a cohort study of complications, reoperations, and resource use in the Medicare population. Spine 1993;18:1463-1470
    Web of Science | Medline

  2. 2

    Deyo RA, Gray DT, Kreuter W, Mirza S, Martin BI. United States trends in lumbar fusion surgery for degenerative conditions. Spine 2005;30:1441-1445
    CrossRef | Web of Science | Medline

  3. 3

    Weinstein JN, Lurie JD, Olson PR, Bronner KK, Fisher ES. United States' trends and regional variations in lumbar spine surgery: 1992-2003. Spine 2006;31:2707-2714
    Web of Science | Medline

  4. 4

    Weinstein J, Birkmeyer J. The Dartmouth atlas of musculoskeletal health care. Chicago: American Hospital Association Press, 2000.

  5. 5

    Boden SD, McCowin PR, Davis DO, Dina TS, Mark AS, Wiesel S. Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects: a prospective investigation. J Bone Joint Surg Am 1990;72:403-408
    Web of Science | Medline

  6. 6

    Jensen MC, Brant-Zawadzki MN, Obuchowski N, Modic MT, Malkasian D, Ross JS. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med 1994;331:69-73
    Full Text | Web of Science | Medline

  7. 7

    Atlas SJ, Deyo RA, Keller RB, et al. The Maine Lumbar Spine Study, Part III:1-year outcomes of surgical and nonsurgical management of lumbar spinal stenosis. Spine 1996;21:1787-1794
    CrossRef | Web of Science | Medline

  8. 8

    Atlas SJ, Keller RB, Robson D, Deyo RA, Singer DE. Surgical and nonsurgical management of lumbar spinal stenosis: four-year outcomes from the Maine Lumbar Spine Study. Spine 2000;25:556-562
    CrossRef | Web of Science | Medline

  9. 9

    Johnsson KE, Uden A, Rosen I. The effect of decompression on the natural course of spinal stenosis: a comparison of surgically treated and untreated patients. Spine 1991;16:615-619
    CrossRef | Web of Science | Medline

  10. 10

    Malmivaara A, Slatis P, Heliovaara M, et al. Surgical or nonoperative treatment for lumbar spinal stenosis? A randomized controlled trial. Spine 2007;32:1-8
    CrossRef | Web of Science | Medline

  11. 11

    Malmivaara A, Statis P, Heliovaara M, et al. Surgical treatment for moderate lumbar spinal stenosis: a randomized controlled trial. In: Proceedings of the International Society for Study of the Lumbar Spine, Porto, Portugal, May 30–June 5, 2004.

  12. 12

    Mariconda M, Fava R, Gatto A, Longo C, Milano C. Unilateral laminectomy for bilateral decompression of lumbar spinal stenosis: a prospective comparative study with conservatively treated patients. J Spinal Disord Tech 2002;15:39-46
    CrossRef | Web of Science | Medline

  13. 13

    Birkmeyer NJ, Weinstein JN, Tosteson AN, et al. Design of the Spine Patient Outcomes Research Trial (SPORT). Spine 2002;27:1361-1372
    CrossRef | Web of Science | Medline

  14. 14

    Weinstein JN, Lurie JD, Tosteson TD, et al. Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT) observational cohort. JAMA 2006;296:2451-2459
    CrossRef | Web of Science | Medline

  15. 15

    Weinstein JN, Tosteson TD, Lurie JD, et al. Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial. JAMA 2006;296:2441-2450
    CrossRef | Web of Science | Medline

  16. 16

    Weinstein JN, Lurie JD, Tosteson TD, et al. Surgical versus nonsurgical treatment for lumbar degenerative spondylolisthesis. N Engl J Med 2007;356:2257-2270
    Full Text | Web of Science | Medline

  17. 17

    Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003;290:1624-1632
    CrossRef | Web of Science | Medline

  18. 18

    Cummins J, Lurie JD, Tosteson TD, et al. Descriptive epidemiology and prior healthcare utilization of patients in the Spine Patient Outcomes Research Trial's (SPORT) three observational cohorts: disc herniation, spinal stenosis, and degenerative spondylolisthesis. Spine 2006;31:806-814
    CrossRef | Web of Science | Medline

  19. 19

    DeMets DL, Lan KK. Interim analysis: the alpha spending function approach. Stat Med 1994;13:1341-1352
    CrossRef | Web of Science | Medline

  20. 20

    Phelan EA, Deyo RA, Cherkin DC, et al. Helping patients decide about back surgery: a randomized trial of an interactive video program. Spine 2001;26:206-211
    CrossRef | Web of Science | Medline

  21. 21

    Weinstein JN. Partnership: doctor and patient: advocacy for informed choice vs. informed consent. Spine 2005;30:269-272
    CrossRef | Web of Science | Medline

  22. 22

    McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66
    CrossRef | Web of Science | Medline

  23. 23

    Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes Study. JAMA 1989;262:907-913
    CrossRef | Web of Science | Medline

  24. 24

    Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483
    CrossRef | Web of Science | Medline

  25. 25

    Ware JE Jr. SF-36 Health survey: manual and interpretation guide. Boston: Nimrod Press, 1993.

  26. 26

    Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine 2000;25:2940-2952
    CrossRef | Web of Science | Medline

  27. 27

    Deyo RA, Diehl AK. Patient satisfaction with medical care for low-back pain. Spine 1986;11:28-30
    CrossRef | Web of Science | Medline

  28. 28

    Patrick DL, Deyo RA, Atlas SJ, Singer DE, Chapin A, Keller RB. Assessing health-related quality of life in patients with sciatica. Spine 1995;20:1899-1908
    CrossRef | Web of Science | Medline

  29. 29

    Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. Philadelphia: Wiley–Interscience, 2004.

  30. 30

    Kuppermann M, Varner RE, Summitt RL Jr, et al. Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial. JAMA 2004;291:1447-1455
    CrossRef | Web of Science | Medline

  31. 31

    Meinert CL. Clinical trials: design, conduct, and analysis. New York: Oxford University Press, 1986.

  32. 32

    Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-1892
    Full Text | Web of Science | Medline

  33. 33

    Ciol MA, Deyo RA, Howell E, Kreif S. An assessment of surgery for spinal stenosis: time trends, geographic variations, complications, and reoperations. J Am Geriatr Soc 1996;44:285-290
    Web of Science | Medline

  34. 34

    Acute low back problems in adults. Bethesda, MD: Agency for Health Care Policy and Research, 1994. (AHCPR publication no. 95-0642.)

  35. 35

    Herniated disc. In: North American Spine Society phase III clinical guidelines for multidisciplinary spine care specialists. LaGrange, IL: North American Spine Society, 2000.

Citing Articles (96)

Citing Articles

  1. 1

    James W Atchison, Heather K Vincent. (2012) Obesity and low back pain: relationships and treatment. Pain Management 2:1, 79-86
    CrossRef

  2. 2

    Vincent J. Devlin, Paul Enker. 2012. When not to operate for spinal disorders. , 157-159.
    CrossRef

  3. 3

    Vincent J. Devlin. 2012. Lumbar spinal stenosis. , 342-346.
    CrossRef

  4. 4

    Ian Whittle, Jennifer Scotland, Fungai Dengu, Shaemala Anpalakhan, Ian J Deary. (2011) Preoperative quality of life in patients with degenerative spinal disorders: many are worse than patients with brain tumours and cancer. British Journal of Neurosurgery1-6
    CrossRef

  5. 5

    Jeffrey N. Katz. (2011) Study Methodologies for Osteoarthritis: Clinical Trials and Tribulations. HSS Journal
    CrossRef

  6. 6

    Hormuzdiyar H. Dasenbrock, Reza Yassari, Timothy F. Witham. 2011. Neurogenic Claudication-Operative Management (Decompression and Fusion). , 686-693.
    CrossRef

  7. 7

    , Fredrik Strömqvist, Bo Jönsson, Björn Strömqvist. (2011) Dural lesions in decompression for lumbar spinal stenosis: incidence, risk factors and effect on outcome. European Spine Journal
    CrossRef

  8. 8

    David W. Polly, Charles Gerald T. Ledonio, Jonathan N. Sembrano, Robert A. Morgan. (2011) Defining Appropriate Spine Care for the Patient as well as Society. Seminars in Spine Surgery
    CrossRef

  9. 9

    Patrick R. Olson, Jon D. Lurie, John Frymoyer, Thomas Walsh, Wenyan Zhao, Tamara S. Morgan, William A. Abdu, James N. Weinstein. (2011) Lumbar Disc Herniation in the Spine Patient Outcomes Research Trial. Spine 36:26, 2324-2332
    CrossRef

  10. 10

    Christopher K. Kepler, Jeffrey A. Rihn, Alexander R. Vaccaro, Todd J. Albert. (2011) Defining the Value of Spine Care to Society. Seminars in Spine Surgery
    CrossRef

  11. 11

    Raja Rampersaud, Kevin Macwan, Nizar N. Mahomed. (2011) Spinal Care in a Single-Payer System: The Canadian Example. Seminars in Spine Surgery
    CrossRef

  12. 12

    C. Ewald, R. Kalff. (2011) Symptomatische lumbale Spinalkanalstenose. Der Nervenarzt 82:12, 1623-1631
    CrossRef

  13. 13

    Owoicho Adogwa, Scott L. Parker, David N. Shau, Stephen K. Mendenhall, Clinton J. Devin, Joseph S. Cheng, Matthew J. McGirt. (2011) Cost per quality-adjusted life year gained of laminectomy and extension of instrumented fusion for adjacent-segment disease: defining the value of surgical intervention. Journal of Neurosurgery: Spine1-6
    CrossRef

  14. 14

    Owoicho Adogwa, Scott L. Parker, David N. Shau, Stephen K. Mendenhall, Oran Aaronson, Joseph S. Cheng, Clinton J. Devin, Matthew J. McGirt. (2011) Cost per quality-adjusted life year gained of revision neural decompression and instrumented fusion for same-level recurrent lumbar stenosis: defining the value of surgical intervention. Journal of Neurosurgery: Spine1-6
    CrossRef

  15. 15

    Y. Raja Rampersaud, Eugene K. Wai, Charles G. Fisher, Albert J.M. Yee, Marcel F.S. Dvorak, Joel A. Finkelstein, Rajiv Gandhi, Edward P. Abraham, Stephen J. Lewis, David I. Alexander, William M. Oxner, J.R. Davey, Nizar Mahomed. (2011) Postoperative improvement in health-related quality of life: a national comparison of surgical treatment for focal (one- to two-level) lumbar spinal stenosis compared with total joint arthroplasty for osteoarthritis. The Spine Journal 11:11, 1033-1041
    CrossRef

  16. 16

    Anna N. A. Tosteson, Tor D. Tosteson, Jon D. Lurie, William Abdu, Harry Herkowitz, Gunnar Andersson, Todd Albert, Keith Bridwell, Wenyan Zhao, Margaret R. Grove, Milton C. Weinstein, James N. Weinstein. (2011) Comparative Effectiveness Evidence From the Spine Patient Outcomes Research Trial. Spine 36:24, 2061-2068
    CrossRef

  17. 17

    Wouter A. Moojen, Mark P. Arts, Ronald H. M. A. Bartels, Wilco C. H. Jacobs, Wilco C. Peul. (2011) Effectiveness of interspinous implant surgery in patients with intermittent neurogenic claudication: a systematic review and meta-analysis. European Spine Journal 20:10, 1596-1606
    CrossRef

  18. 18

    Owoicho Adogwa, Scott L. Parker, David Shau, Stephen K. Mendelhall, Joseph Cheng, Oran Aaronson, Clinton J. Devin, Matthew J. McGirt. (2011) Long-term outcomes of revision fusion for lumbar pseudarthrosis. Journal of Neurosurgery: Spine 15:4, 393-398
    CrossRef

  19. 19

    Charles A. Reitman. (2011) Commentary: Indicated surgery is beneficial. The Spine Journal 11:10, 940-941
    CrossRef

  20. 20

    Francisco M. Kovacs, Gerard Urrútia, José Domingo Alarcón. (2011) Surgery Versus Conservative Treatment for Symptomatic Lumbar Spinal Stenosis. Spine 36:20, E1335-E1351
    CrossRef

  21. 21

    Matthew J. Smith. (2011) Accountable disease management of spine pain. The Spine Journal 11:9, 807-815
    CrossRef

  22. 22

    Sanghamitra Basu. (2011) Mild Procedure. The Clinical Journal oF Pain1
    CrossRef

  23. 23

    S. Samuel Bederman, Charles D. Rosen, Nitin N. Bhatia, P. Douglas Kiester, Ranjan Gupta. (2011) Drivers of Surgery for the Degenerative Hip, Knee, and Spine: A Systematic Review. Clinical Orthopaedics and Related Research®
    CrossRef

  24. 24

    Karen Maloney Backstrom, Julie M. Whitman, Timothy W. Flynn. (2011) Lumbar spinal stenosis-diagnosis and management of the aging spine. Manual Therapy 16:4, 308-317
    CrossRef

  25. 25

    Aravind Athiviraham, Zubair A. Wali, David Yen. (2011) Predictive factors influencing clinical outcome with operative management of lumbar spinal stenosis. The Spine Journal 11:7, 613-617
    CrossRef

  26. 26

    Steven J. Atlas. (2011) Commentary: Predictive factors influencing clinical outcome with operative management of lumbar spinal stenosis. The Spine Journal 11:7, 620-621
    CrossRef

  27. 27

    Pär Slätis, Antti Malmivaara, Markku Heliövaara, Päivi Sainio, Arto Herno, Jyrki Kankare, Seppo Seitsalo, Kaj Tallroth, Veli Turunen, Paul Knekt, Heikki Hurri. (2011) Long-term results of surgery for lumbar spinal stenosis: a randomised controlled trial. European Spine Journal 20:7, 1174-1181
    CrossRef

  28. 28

    Grant Skidmore, Stacey J. Ackerman. (2011) Letter to the Editor. Journal of Neurosurgery: Spine 15:1, 125-126
    CrossRef

  29. 29

    Nagy Mekhail, Ricardo Vallejo, Mark H. Coleman, Ramsin M. Benyamin. (2011) Long-Term Results of Percutaneous Lumbar Decompression mild® for Spinal Stenosis. Pain Practiceno-no
    CrossRef

  30. 30

    Sanna Sinikallio, Heli Koivumaa-Honkanen, Timo Aalto, Olavi Airaksinen, Soili M. Lehto, Heimo Viinamäki. (2011) Life dissatisfaction in the pre-operative and early recovery phase predicts low functional ability and coping among post-operative patients with lumbar spinal stenosis: a 2-year prospective study. Disability and Rehabilitation 33:7, 599-604
    CrossRef

  31. 31

    Chin-wern Chan, Philip Peng. (2011) Failed Back Surgery Syndrome. Pain Medicine 12:4, 577-606
    CrossRef

  32. 32

    Andrew J Schoenfeld, Christopher M Bono. (2011) Use of surgery for the management of lumbar spinal stenosis. Pain Management 1:2, 139-145
    CrossRef

  33. 33

    S. Samuel Bederman, Peter C. Coyte, Hans J. Kreder, Nizar N. Mahomed, Warren J. McIsaac, James G. Wright. (2011) Whoʼs in the Driverʼs Seat? The Influence of Patient and Physician Enthusiasm on Regional Variation in Degenerative Lumbar Spinal Surgery. Spine 36:6, 481-489
    CrossRef

  34. 34

    Miho Sekiguchi, Takafumi Wakita, Koji Otani, Yoshihiro Onishi, Shunichi Fukuhara, Shinichi Kikuchi, Shinichi Konno. (2011) Development and validation of a symptom scale for lumbar spinal stenosis. Spine1
    CrossRef

  35. 35

    Adam Pearson, Emily Blood, Jon Lurie, William Abdu, Dilip Sengupta, John Frymoyer Frymoyer, James Weinstein. (2011) Predominant Leg Pain Is Associated With Better Surgical Outcomes in Degenerative Spondylolisthesis and Spinal Stenosis. Spine 36:3, 219-229
    CrossRef

  36. 36

    &NA;. (2011) Trends, Major Medical Complications, and Charges Associated With Surgery for Lumbar Spinal Stenosis in Older Adults. Survey of Anesthesiology 55:1, 20-21
    CrossRef

  37. 37

    Jonathan Skinner. 2011. Causes and Consequences of Regional Variations in Health Care. , 45-93.
    CrossRef

  38. 38

    Gijsbert M Overdevest, Pim AJ Luijsterburg, Ronald Brand, Bart W Koes, Sita MA Bierma-Zeinstra, Just AH Eekhof, Carmen LAM Vleggeert-Lankamp, Wilco C Peul. (2011) Design of the Verbiest trial: cost-effectiveness of surgery versus prolonged conservative treatment in patients with lumbar stenosis. BMC Musculoskeletal Disorders 12:1, 57
    CrossRef

  39. 39

    Bohdan Wolodymyr Chopko. (2011) A novel method for treatment of lumbar spinal stenosis in high-risk surgical candidates: pilot study experience with percutaneous remodeling of ligamentum flavum and lamina. Journal of Neurosurgery: Spine 14:1, 46-50
    CrossRef

  40. 40

    Mitchell K Freedman, Alan S Hilibrand, Emily A Blood, Wenyan Zhao, Todd J Albert, Alexander Vacarro, Christina V Oleson, Tamara S. Morgan, James N Weinstein. (2011) The Impact of Diabetes On the Outcomes of Surgical and Nonsurgical Treatment of Patients in the Spine Patient Outcomes Research Trial (SPORT). Spine1
    CrossRef

  41. 41

    William Blake Rodgers, Edward J. Gerber, Jody A. Rodgers. (2010) Lumbar Fusion in Octogenarians. Spine 35:Supplement, S355-S360
    CrossRef

  42. 42

    Carl Lauryssen. (2010) Technical Advances in Minimally Invasive Surgery. Spine 35:Supplement, S287-S293
    CrossRef

  43. 43

    William Raffaeli, Donatella Righetti, Jessica Andruccioli, Donatella Sarti. (2010) Epidural space and chronic pain. European Journal of Pain Supplements 4:S4, 269-272
    CrossRef

  44. 44

    Sven Rainer Kantelhardt, Elisabeth Török, Jens Gempt, Michael Stoffel, Florian Ringel, Carsten Stüer, Bernhard Meyer. (2010) Safety and efficacy of a new percutaneously implantable interspinous process device. Acta Neurochirurgica 152:11, 1961-1967
    CrossRef

  45. 45

    Anne F. Mannion, R. Denzler, J. Dvorak, D. Grob. (2010) Five-year outcome of surgical decompression of the lumbar spine without fusion. European Spine Journal 19:11, 1883-1891
    CrossRef

  46. 46

    Nobuhiro Hara, Hiroyuki Oka, Takashi Yamazaki, Katsushi Takeshita, Motoaki Murakami, Kazuto Hoshi, Sei Terayama, Atsushi Seichi, Kozo Nakamura, Hiroshi Kawaguchi, Ko Matsudaira. (2010) Predictors of residual symptoms in lower extremities after decompression surgery on lumbar spinal stenosis. European Spine Journal 19:11, 1849-1854
    CrossRef

  47. 47

    Jens Gempt, Ralf D. Rothoerl, Astrid Grams, Bernhard Meyer, Florian Ringel. (2010) Effect of Lumbar Spinal Stenosis and Surgical Decompression on Erectile Function. Spine 35:22, E1172-E1177
    CrossRef

  48. 48

    Christy C. Tomkins-Lane, Michele C. Battié. (2010) Validity and Reproducibility of Self-report Measures of Walking Capacity in Lumbar Spinal Stenosis. Spine1
    CrossRef

  49. 49

    Michael O. Kelleher, Marcus Timlin, Oma Persaud, Yoga Raja Rampersaud. (2010) Success and Failure of Minimally Invasive Decompression for Focal Lumbar Spinal Stenosis in Patients With and Without Deformity. Spine 35:19, E981-E987
    CrossRef

  50. 50

    S. Samuel Bederman, Warren J. McIsaac, Peter C. Coyte, Hans J. Kreder, Nizar N. Mahomed, James G. Wright. (2010) Referral Practices for Spinal Surgery are Poorly Predicted by Clinical Guidelines and Opinions of Primary Care Physicians. Medical Care 48:9, 852-858
    CrossRef

  51. 51

    Triantafyllos Bouras, George Stranjalis, Maria Loufardaki, Ilias Sourtzis, Lampis C. Stavrinou, Damianos E. Sakas. (2010) Predictors of long-term outcome in an elderly group after laminectomy for lumbar stenosis. Journal of Neurosurgery: Spine 13:3, 329-334
    CrossRef

  52. 52

    Neilly Buckalew, Marc W. Haut, Howard Aizenstein, Lisa Morrow, Subashan Perera, Hiroto Kuwabara, Debra K. Weiner. (2010) Differences in Brain Structure and Function in Older Adults with Self-Reported Disabling and Nondisabling Chronic Low Back Pain. Pain Medicine 11:8, 1183-1197
    CrossRef

  53. 53

    Daniel Omoto, S. Samuel Bederman, Albert J. M. Yee, Hans J. Kreder, Joel A. Finkelstein. (2010) How do validated measures of functional outcome compare with commonly used outcomes in administrative database research for lumbar spinal surgery?. European Spine Journal 19:8, 1369-1377
    CrossRef

  54. 54

    Er Chen, Kuo Bianchini Tong, Marianne Laouri. (2010) Surgical treatment patterns among Medicare beneficiaries newly diagnosed with lumbar spinal stenosis. The Spine Journal 10:7, 588-594
    CrossRef

  55. 55

    Mark G. Burnett, Sherman C. Stein, Ronald H. M. A. Bartels. (2010) Cost-effectiveness of current treatment strategies for lumbar spinal stenosis: nonsurgical care, laminectomy, and X-STOP. Journal of Neurosurgery: Spine 13:1, 39-46
    CrossRef

  56. 56

    Richard A. Deyo. (2010) Treatment of lumbar spinal stenosis: a balancing act. The Spine Journal 10:7, 625-627
    CrossRef

  57. 57

    Jorm Nellensteijn, Raymond Ostelo, Ronald Bartels, Wilco Peul, Barend Royen, Maurits Tulder. (2010) Transforaminal endoscopic surgery for lumbar stenosis: a systematic review. European Spine Journal 19:6, 879-886
    CrossRef

  58. 58

    A. Reinhardt, S. Hufnagel. (2010) Langzeitergebnisse des interspinösen Distraktionssystems X-STOP. Der Orthopäde 39:6, 573-579
    CrossRef

  59. 59

    James N. Weinstein, Tor D. Tosteson, Jon D. Lurie, Anna Tosteson, Emily Blood, Harry Herkowitz, Frank Cammisa, Todd Albert, Scott D. Boden, Alan Hilibrand, Harley Goldberg, Sigurd Berven, Howard An. (2010) Surgical Versus Nonoperative Treatment for Lumbar Spinal Stenosis Four-Year Results of the Spine Patient Outcomes Research Trial. Spine1
    CrossRef

  60. 60

    Mladen Djurasovic, Steven D. Glassman, Leah Y. Carreon, John R. Dimar. (2010) Contemporary Management of Symptomatic Lumbar Spinal Stenosis. Orthopedic Clinics of North America 41:2, 183-191
    CrossRef

  61. 61

    Stephane Genevay, Steven J. Atlas. (2010) Lumbar Spinal Stenosis. Best Practice & Research Clinical Rheumatology 24:2, 253-265
    CrossRef

  62. 62

    Daniel K. Park, Howard S. An, Jon D. Lurie, Wenyan Zhao, Anna Tosteson, Tor D. Tosteson, Harry Herkowitz, Thomas Errico, James N. Weinstein. (2010) Does Multilevel Lumbar Stenosis Lead to Poorer Outcomes?. Spine 35:4, 439-446
    CrossRef

  63. 63

    Karl-Stefan Delank, Erol Gercek, Sebastian Kuhn, Frank Hartmann, H. Hely, Marc Röllinghoff, M. A. Rothschild, H. Stützer, Rolf Sobottke, Peer Eysel. (2010) How does spinal canal decompression and dorsal stabilization affect segmental mobility? A biomechanical study. Archives of Orthopaedic and Trauma Surgery 130:2, 285-292
    CrossRef

  64. 64

    Adam Pearson, Emily Blood, Jon Lurie, Tor Tosteson, William A. Abdu, Alan Hillibrand, Keith Bridwell, James Weinstein. (2010) Degenerative Spondylolisthesis Versus Spinal Stenosis. Spine 35:3, 298-305
    CrossRef

  65. 65

    Phyo KIM, Ryu KUROKAWA, Kazushige ITOKI. (2010) Technical Advancements and Utilization of Spine Surgery. Neurologia medico-chirurgica 50:9, 853-858
    CrossRef

  66. 66

    , Seiji Ohtori, Toshinori Ito, Masaomi Yamashita, Yasuaki Murata, Tatsuo Morinaga, Jiro Hirayama, Tomoaki Kinoshita, Hiromi Ataka, Takana Koshi, Toshihiko Sekikawa, Masayuki Miyagi, Takaaki Tanno, Munetaka Suzuki, Yasuchika Aoki, Takato Aihara, Shinichiro Nakamura, Kiyoshi Yamaguchi, Toshiyuki Tauchi, Kenji Hatakeyama, Keiichi Takata, Hiroaki Sameda, Tomoyuki Ozawa, Eiji Hanaoka, Hirohito Suzuki, Tsutomu Akazawa, Kaoru Suseki, Hajime Arai, Masahiro Kurokawa, Yawara Eguchi, Miyako Suzuki, Yuzuru Okamoto, Jin Miyagi, Masatsune Yamagata, Tomoaki Toyone, Kazuhisa Takahashi. (2010) Evaluation of low back pain using the Japanese Orthopaedic Association Back Pain Evaluation Questionnaire for lumbar spinal disease in a multicenter study: differences in scores based on age, sex, and type of disease. Journal of Orthopaedic Science 15:1, 86-91
    CrossRef

  67. 67

    Erin E. Krebs, Jon D. Lurie, Gilbert Fanciullo, Tor D. Tosteson, Emily A. Blood, Timothy S. Carey, James N. Weinstein. (2010) Predictors of Long-Term Opioid Use Among Patients With Painful Lumbar Spine Conditions. The Journal of Pain 11:1, 44-52
    CrossRef

  68. 68

    S Samuel Bederman, Nizar N. Mahomed, Hans J. Kreder, Warren J. McIsaac, Peter C. Coyte, James G. Wright. (2010) In the Eye of the Beholder. Spine 35:1, 108-115
    CrossRef

  69. 69

    Sung-Joo Ryu, In-Soo Kim. (2010) Interspinous Implant with Unilateral Laminotomy for Bilateral Decompression of Degenerative Lumbar Spinal Stenosis in Elderly Patients. Journal of Korean Neurosurgical Society 47:5, 338
    CrossRef

  70. 70

    David G. Borenstein. 2010. Management of Mechanical Lumbar Spine Disease. , 356-369.
    CrossRef

  71. 71

    Luca Papavero, Marco Thiel, Erik Fritzsche, Christina Kunze, Manfred Westphal, Ralph Kothe. (2009) LUMBAR SPINAL STENOSIS. Neurosurgery 65, ons182-ons187
    CrossRef

  72. 72

    Lars Westergaard, John Hauerberg, Jacob B. Springborg. (2009) Outcome After Surgical Treatment for Lumbar Spinal Stenosis. Spine 34:25, E930-E935
    CrossRef

  73. 73

    Andrew P. White, Todd J. Albert. (2009) Evidence-Based Treatment of Lumbar Spinal Stenosis. Seminars in Spine Surgery 21:4, 230-237
    CrossRef

  74. 74

    Adam M. Pearson, James N. Weinstein. (2009) Pearls and Pitfalls in Evidence Based Medicine: What We've Learned About Outcomes Research in Spine Surgery. Seminars in Spine Surgery 21:4, 264-267
    CrossRef

  75. 75

    Rolf Sobottke, Klaus Schlüter-Brust, Thomas Kaulhausen, Marc Röllinghoff, Britta Joswig, Hartmut Stützer, Peer Eysel, Patrick Simons, Johannes Kuchta. (2009) Interspinous implants (X Stop®, Wallis®, Diam®) for the treatment of LSS: is there a correlation between radiological parameters and clinical outcome?. European Spine Journal 18:10, 1494-1503
    CrossRef

  76. 76

    Christy C. Tomkins, Michele C. Battié, Todd Rogers, Harry Jiang, Stewart Petersen. (2009) A Criterion Measure of Walking Capacity in Lumbar Spinal Stenosis and Its Comparison With a Treadmill Protocol. Spine 34:22, 2444-2449
    CrossRef

  77. 77

    William A. Abdu, Jon D. Lurie, Kevin F. Spratt, Anna N. A. Tosteson, Wenyan Zhao, Tor D. Tosteson, Harry Herkowitz, Michael Longely, Scott D. Boden, Sanford Emery, James N. Weinstein. (2009) Degenerative Spondylolisthesis. Spine 34:21, 2351-2360
    CrossRef

  78. 78

    Niki Matveeva, Miodrag Vrchakovski. (2009) Lumbar Spinal Stenosis in Older Adults - Gender Differences. Macedonian Journal of Medical Sciences 2:3, 200-204
    CrossRef

  79. 79

    Sanna Sinikallio, Timo Aalto, Heli Koivumaa-Honkanen, Olavi Airaksinen, Arto Herno, Heikki Kröger, Heimo Viinamäki. (2009) Life dissatisfaction is associated with a poorer surgery outcome and depression among lumbar spinal stenosis patients: a 2-year prospective study. European Spine Journal 18:8, 1187-1193
    CrossRef

  80. 80

    Jens Ivar Brox. (2009) The contribution of RCTs to quality management and their feasibility in practice. European Spine Journal 18:S3, 279-293
    CrossRef

  81. 81

    Manuel Castro-Menéndez, Jose A. Bravo-Ricoy, Roberto Casal-Moro, Moisés Hernández-Blanco, Francisco J. Jorge-Barreiro. (2009) MIDTERM OUTCOME AFTER MICROENDOSCOPIC DECOMPRESSIVE LAMINOTOMY FOR LUMBAR SPINAL STENOSIS. Neurosurgery 65:1, 100-110
    CrossRef

  82. 82

    Eberhard Siebert, Harald Prüss, Randolf Klingebiel, Vieri Failli, Karl M. Einhäupl, Jan M. Schwab. (2009) Lumbar spinal stenosis: syndrome, diagnostics and treatment. Nature Reviews Neurology 5:7, 392-403
    CrossRef

  83. 83

    Giuseppe M.V. Barbagallo, Giuseppe Olindo, Leonardo Corbino, Vincenzo Albanese. (2009) ANALYSIS OF COMPLICATIONS IN PATIENTS TREATED WITH THE X-STOP INTERSPINOUS PROCESS DECOMPRESSION SYSTEM. Neurosurgery 65:1, 111-120
    CrossRef

  84. 84

    Vijay Agarwal, Michael Wildstein, John B. Tillman, William L. Pelkey, Todd F. Alamin. (2009) Lumbar intersegmental spacing and angulation in the modified lateral decubitus position versus variants of prone positioning. The Spine Journal 9:7, 580-584
    CrossRef

  85. 85

    Ronald H.M.A. Bartels. (2009) Evidence-Based Medicine. Neurosurgery 64:6, E1206
    CrossRef

  86. 86

    Robert Gunzburg, Marek Szpalski, Stuart A. Callary, Christopher J. Colloca, Victor Kosmopoulos, Deed Harrison, Robert J. Moore. (2009) Effect of a novel interspinous implant on lumbar spinal range of motion. European Spine Journal 18:5, 696-703
    CrossRef

  87. 87

    Roger Chou, John D. Loeser, Douglas K. Owens, Richard W. Rosenquist, Steven J. Atlas, Jamie Baisden, Eugene J. Carragee, Martin Grabois, Donald R. Murphy, Daniel K. Resnick, Steven P. Stanos, William O. Shaffer, Eric M. Wall. (2009) Interventional Therapies, Surgery, and Interdisciplinary Rehabilitation for Low Back Pain. Spine 34:10, 1066-1077
    CrossRef

  88. 88

    Zarife Koc, Suheda Ozcakir, Koncuy Sivrioglu, Alp Gurbet, Selcuk Kucukoglu. (2009) Effectiveness of Physical Therapy and Epidural Steroid Injections in Lumbar Spinal Stenosis. Spine 34:10, 985-989
    CrossRef

  89. 89

    Roger Chou, Jamie Baisden, Eugene J. Carragee, Daniel K. Resnick, William O. Shaffer, John D. Loeser. (2009) Surgery for Low Back Pain. Spine 34:10, 1094-1109
    CrossRef

  90. 90

    Eugene J. Carragee, Richard A. Deyo, Francisco M. Kovacs, Wilco C. Peul, Jon D. Lurie, Gerard Urrútia, Terry P. Corbin, Mark L. Schoene. (2009) Clinical Research. Spine 34:5, 423-430
    CrossRef

  91. 91

    Steven D. Glassman, Leah Y. Carreon, Mladen Djurasovic, John R. Dimar, John R. Johnson, Rolando M. Puno, Mitchell J. Campbell. (2009) Lumbar fusion outcomes stratified by specific diagnostic indication. The Spine Journal 9:1, 13-21
    CrossRef

  92. 92

    James J. Chien, Zahid H. Bajwa. (2008) What is mechanical back pain and how best to treat it?. Current Pain and Headache Reports 12:6, 406-411
    CrossRef

  93. 93

    James N. Weinstein, Jon D. Lurie, Tor D. Tosteson, Anna N. A. Tosteson, Emily A. Blood, William A. Abdu, Harry Herkowitz, Alan Hilibrand, Todd Albert, Jeffrey Fischgrund. (2008) Surgical Versus Nonoperative Treatment for Lumbar Disc Herniation. Spine 33:25, 2789-2800
    CrossRef

  94. 94

    (2008) Surgery is superior to nonsurgical treatment for spinal stenosis. Nature Clinical Practice Rheumatology 4:6, 282-282
    CrossRef

  95. 95

    Kurt Samson. (2008) Better Spinal Stenosis Outcomes with Surgery, Major Study Finds. Neurology Today 8:7, 1,20
    CrossRef

  96. 96

    Katz, Jeffrey N., Harris, Mitchel B., . (2008) Lumbar Spinal Stenosis. New England Journal of Medicine 358:8, 818-825
    Full Text